Clinical Trial Update: The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the safety and efficacy of a bedaquiline-delamanid-linezolid regimen in pulmonary MDR-TB and rifampicin-resistant TB; trial cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis Multidrug-resistant
• Tuberculosis Rifampicin-resistant

Drugs mentioned

• Deltyba (delamanid)
• SIRTURO (bedaquiline fumarate)
• ZYVOX (LINEZOLID)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Pulmonary Tuberculosis | Phase 4 | Status: RECRUITING